Related Experiment Video
Updated: Jun 10, 2025

Diagnosis of Hirschsprung's Disease by Immunostaining Rectal Suction Biopsies for Calretinin, S100 Protein and Protein Gene Product 9.5
Published on: April 26, 2019
Langerhans Cell Histiocytosis Masked by Constipation: A Case Report and Literature Review
Alexis N Reinders1, Farrah Gaston2, Haroon Ali3
1Pediatrics, University of Illinois College of Medicine, Peoria, USA.
Abstract:
Langerhans cell histiocytosis (LCH) is a rare histiocytic neoplastic disorder that presents in all age groups, although it often affects young children. Patients typically present with lytic bone lesions and an erythematous rash, though other systems such as the digestive, endocrine, lymphatic, and respiratory systems can be involved. We present a case of LCH that was masked by symptoms of constipation. The patient was a three-year-old female who presented with a primary complaint of constipation accompanied by abdominal and back pain. Further investigation identified an L3 lesion on lumbar spine magnetic resonance imaging, for which a pediatric neurosurgeon performed an open reduction and internal fixation. Pathology confirmed the diagnosis of LCH. This was followed by one year of chemotherapy. To date, she has not had a recurrence of LCH. This case demonstrates the importance of generating a broad differential diagnosis and determining and treating the etiology of a patient's symptoms rather than the symptoms alone. Physicians must maintain a high index of suspicion for rare diagnoses when symptoms have persisted and more common etiologies have been ruled out. A thorough neurological exam should be performed for all patients with constipation due to an unknown etiology, especially when accompanied by back pain. Although the patient did not present with gastrointestinal (GI) involvement of LCH, nonspecific GI symptoms such as diffuse abdominal pain and bloody diarrhea have been associated with this rare diagnosis. We thoroughly review the literature regarding both GI involvement of LCH and cases of LCH that present with accompanying GI symptoms. Additionally, we highlight the clinical treatment options of LCH.
Related Concept Videos
Drugs for Treatment of Constipation-Predominant IBS
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Other Disorders of Digestive System
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

